2 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Type II Diabetes: new trials by email Literature Review of Type II Diabetes trials Research Report on Type II Diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus PIEMONTE, PIEMONTE PLACEBO, EMPAGLIFLOZIN - Type II Diabetes | Phase 3 | Recruiting | EMS | 480 | 2024-10-08 | 2025-12-08 |
| Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes YH14755, Metformin, Rosuvastatin - Dyslipidemia, Type II Diabetes | Phase 3 | Completed | Yuhan Corporation | 249 | 2015-11-04 | 2018-10-03 |
| Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) Metformin/Atorvastatin 1500mg/40mg, QD, Metformin 1500mg, QD, Atorvastatin 40mg, QD - Type II Diabetes, Dyslipidemia | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 185 | 2015-08-01 | 2023-06-18 |
Diabetes Mellitus, Type 2 (3) · Dyslipidemias (2)
Diabetes Mellitus (3) · Endocrine System Diseases (3) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Lipid Metabolism Disorders (2)
Metformin (2) · Atorvastatin (1) · Pioglitazone (1) · Rosuvastatin Calcium (1) · empagliflozin (1)
Daewoong Pharmaceutical Co. LTD. (1) · EMS (1) · Yuhan Corporation (1)
South Korea (2) · Brazil (1)